# A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

> **NCT04081844** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HCP1306
- **DRUG:** HGP0904
- **DRUG:** HGP0608

## Key facts

- **NCT ID:** NCT04081844
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2018-06-28
- **Final completion:** 2018-06-28
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081844, "A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04081844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*